Phase 1 Rhinosinusitis Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Bambusa Therapeutics64 enrolled12 locationsNCT07436949
Recruiting
Phase 1
A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray
Chronic Rhinosinusitis (CRS)
VivaVision Biotech, Inc60 enrolled1 locationNCT07259538
Recruiting
Phase 1Phase 2
Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial
Chronic Rhinosinusitis (CRS)
St. Paul's Hospital, Canada100 enrolled1 locationNCT06750302